Palvella Therapeutics’ drug candidate QTORIN rapamycin receives US patent: Wayne, Pennsylvania Saturday, June 21, 2025, 13:00 Hrs [IST] Palvella Therapeutics Inc, a clinical-sta ...

Moleculin Biotech gets US FDA positive feedback on paediatric study plan for Annamycin in children with R/R AML: Houston Saturday, June 21, 2025, 15:00 Hrs [IST] Moleculin Biotech ...

The Motley Fool. DATE Tuesday, June 17, 2025, at 4:30 p.m. EDT CALL PARTICIPANTS Chairman and Chief Executive Officer — ...

Capricor Therapeutics (CAPR) announced four-year safety and efficacy results from its ongoing HOPE-2 Open-Label Extension study of Deramiocel, the Company’s lead cell therapy candidate for Duchenne ...

Perverts and violent abusers are among the latest Welsh police officers kicked off the force. Through Freedom of Information ...

Unicycive Therapeutics, Inc. has announced a 1-for-10 reverse stock split of its common stock, effective from 4:01 p.m.